Literature DB >> 6852027

Carboxylesterases in rat and human sera and their relationship of serum aryl acylamidases and cholinesterases.

T Tsujita, H Okuda.   

Abstract

The three enzyme activities, carboxylesterase, aryl acylamidase and cholinesterase activities, have been found in rat and human sera. Rat serum carboxylesterase associated with serum aryl acylamidase activity, but not with serum cholinesterase activity, was purified by ammonium sulfate precipitation, followed by successive chromatographies on DEAE-cellulose, blue Sepharose and QAE-Sephadex, and then electrophoresis. Evidence for the identity of the two enzymes, carboxylesterase and aryl acylamidase, was their co-elution profiles and co-purification in the different steps, including electrophoresis, with constant ratios of specific activities and percentage recoveries. Human serum carboxylesterase associated with serum cholinesterase, purified earlier, was compared with the rat serum esterase. Human serum carboxylesterase and aryl acylamidase activities were inhibited by serotonin and neostigmine, whereas rat serum carboxylesterase and aryl acylamidase activities were not affected by these compounds. Tyramine activated human but not rat aryl acylamidase. Rat and human serum esterase activities were both strongly inhibited by the diisopropylfluorophosphate. Both esterases catalyzed the hydrolysis of short-chain triacylglycerols, such as tributyrin, and medium-chain monoacylglycerols, such as monocaprin, but not the hydrolysis of long-chain triacylglycerols.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6852027     DOI: 10.1111/j.1432-1033.1983.tb07450.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Esterase-activated release of naproxen from supramolecular nanofibres.

Authors:  Martin Conda-Sheridan; Sungsoo S Lee; Adam T Preslar; Samuel I Stupp
Journal:  Chem Commun (Camb)       Date:  2014-11-18       Impact factor: 6.222

2.  Screening of lipase inhibitors from marine algae.

Authors:  N Bitou; M Ninomiya; T Tsujita; H Okuda
Journal:  Lipids       Date:  1999-05       Impact factor: 1.880

3.  Evidence for a Zn(2+)-binding site in human serum butyrylcholinesterase.

Authors:  C D Bhanumathy; A S Balasubramanian
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

4.  Reactivity and toxicity of atracurium and its metabolites in vitro.

Authors:  V Nigrovic; J B Pandya; J E Klaunig; K Fry
Journal:  Can J Anaesth       Date:  1989-05       Impact factor: 5.063

5.  Amine prodrugs which utilize hydroxy amide lactonization. II. A potential esterase-sensitive amide prodrug.

Authors:  K L Amsberry; A E Gerstenberger; R T Borchardt
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

6.  Isolation of a tripeptide (Ala-Gly-Ser) exhibiting weak acetylthiocholine hydrolyzing activity from a high-salt soluble form of monkey diaphragm acetylcholinesterase.

Authors:  L D Jayanthi; A S Balasubramanian
Journal:  Neurochem Res       Date:  1992-04       Impact factor: 3.996

7.  The peptidase activity of human serum butyrylcholinesterase: studies using monoclonal antibodies and characterization of the peptidase.

Authors:  R V Rao; A S Balasubramanian
Journal:  J Protein Chem       Date:  1993-02

8.  Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters.

Authors:  J M Gearhart; G W Jepson; H J Clewell; M E Andersen; R B Conolly
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

9.  Saponins and Flavonoids from Adzuki Bean (Vigna angularis L.) Ameliorate High-Fat Diet-Induced Obesity in ICR Mice.

Authors:  Rui Liu; Yinan Zheng; Zongwei Cai; Baojun Xu
Journal:  Front Pharmacol       Date:  2017-09-27       Impact factor: 5.810

10.  A carboxylesterase-selective ratiometric fluorescent two-photon probe and its application to hepatocytes and liver tissues.

Authors:  Sang Jun Park; Hyo Won Lee; Hye-Ri Kim; Chulhun Kang; Hwan Myung Kim
Journal:  Chem Sci       Date:  2016-02-23       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.